Royalty Pharma (RPRX) EPS (Basic) (QoQ) (2020 - 2026)
Royalty Pharma (RPRX) EPS (Basic) (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Royalty Pharma |
23.13 Bn |
25.57 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
34.00% |
| Dec 31, 2025 |
-25.37% |
| Sep 30, 2025 |
857.14% |
| Jun 30, 2025 |
-87.27% |
| Mar 31, 2025 |
17.02% |
| Dec 31, 2024 |
-61.48% |
| Sep 30, 2024 |
430.43% |
| Jun 30, 2024 |
2,200.00% |
| Mar 31, 2024 |
-99.10% |
| Dec 31, 2023 |
593.75% |
| Sep 30, 2023 |
-68.63% |
| Jun 30, 2023 |
-32.89% |
| Mar 31, 2023 |
173.08% |
| Dec 31, 2022 |
-425.00% |
| Sep 30, 2022 |
-54.29% |
| Jun 30, 2022 |
483.33% |
| Mar 31, 2022 |
-7.26% |
| Dec 31, 2021 |
-46.09% |
| Sep 30, 2021 |
-77.78% |
| Jun 30, 2021 |
500.00% |
